QR Kod

Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis

Abstract Background The comparative safety and efficacy between anti-vascular endothelial growth factor agents (anti-VEGFs) and between combined therapies for patients with neovascular age-related macular degeneration (nAMD) is unclear. We conducted a systematic review to examine the comparative saf...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Andrea C. Tricco, Sonia M. Thomas, Erin Lillie, Areti Angeliki Veroniki, Jemila S. Hamid, Ba’ Pham, Taehoon Lee, Arnav Agarwal, Jane P. Sharpe, Alistair Scott, Rachel Warren, Ronak Brahmbhatt, Erin Macdonald, Ghayath Janoudi, Rajeev H. Muni, Carolina L. M. Francisconi, Trevor Richter, Sharon E. Straus
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2021-12-01
Seri Bilgileri:Systematic Reviews
Konular:
Ranibizumab
Bevacizumab
Aflibercept
Conbercept
Brolucizumab
Anti-vascular endothelial growth factor
Online Erişim:https://doi.org/10.1186/s13643-021-01864-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller